Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
300 results
  1. NLM Digital Collections - AIDS Tracer M, 9/5/1984-9/28/1984 
    https://resource.nlm.nih.gov/101637321X17
    ... of the cases in the 483 ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH ... T-cell antibody (0-0-5%). No anti-graft-versus-host disease prophylaxis was given after transplantation. Rapid engraftment was ...
  2. NLM Digital Collections - Hospital literature index (Volume 49) 
    resource.nlm.nih.gov/7807587X36
    ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ...
  3. NLM Digital Collections - Gene therapies for sickle cell disease : final evidence report 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 21, 2023
    resource.nlm.nih.gov/9918697383806676
    ... Drug Administration g/dL gram per deciliter GVHD Graft-versus-host disease HLA Human leukocyte antigen HSCT Hematopoietic stem cell ... HSCT has a risk of graft failure/rejection, graft-versus-host disease (GVHD), acute complications during the transplant process, and ...
  4. NLM Digital Collections - Betibeglogene autotemcel for beta thalassemia : effectiveness and value : final evidence ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022
    resource.nlm.nih.gov/9918506283406676
    ... cel, HSCT places the recipient at risk for graft versus host disease. As we heard from patients living with TDT ... that it does not impose a risk of graft-versus-host disease or rejection. Despite these risks, advances in HSCT ...
  5. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
    resource.nlm.nih.gov/9918645959006676
    ... FDA Approvals FDA Approves First Drug to Prevent Graft Versus Host Disease On December 15, 2021, the FDA approved Orencia (abatacept) for the prophylaxis (prevention) of acute graft versus host disease (aGVHD), a condition that occurs when donor bone ...
  6. NLM Digital Collections - Analysis of supply, distribution, demand, and access issues associated with immune globulin ... 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007
    resource.nlm.nih.gov/101615447
    ... pneumonia of infectious or idiopathic causes, and acute graft-versus-host disease after transplantation Source: Orange et al., 2006 An ... reduce the incidences of infection and to prevent graft versus host disease, in which the new donor cells attack the ...
  7. NLM Digital Collections - Hospital and health administration index (Volume 55) 
    resource.nlm.nih.gov/9601831X5
    ... A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation. Parrish RS, et al. ... A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation. Parrish RS, et al. ...
  8. NLM Digital Collections - Antilymphocyte serum mode of action and clinical applicability 
    Publication: Fort Sam Houston, Tex. : The Academy, [1975]
    resource.nlm.nih.gov/7604254A
    ... used in the prevention of graft rejection and graft-versus-host disease. Cpt. Sell begins by giving a history of ... used in the prevention of graft rejection and graft-versus-host disease. Cpt. Sell begins by giving a history of ...
  9. NLM Digital Collections - Hospital literature index (Volume 43) 
    resource.nlm.nih.gov/7807587X30
    ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ...
  10. NLM Digital Collections - Manufacture of blood components using a pathogen reduction device in blood establishments : ... 
    Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, November 2021
    resource.nlm.nih.gov/9918351275906676
    ... platelets to prevent the risk of transfusion- associated graft versus host disease (TA-GVHD)? Yes. As described in the FDA- ... to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD). 2 Contains Nonbinding Recommendations 5. Can ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last